Log In
Friday 28th October 2016

Drug that can kill MRSA?

19th May 2008

A team of scientists in Britain have said they are carrying out tests on a compound which can eradicate the superbug MRSA.


The research is being performed at Destiny Pharma, a pharmaceutical firm based in Brighton, with the aim of employing the drug to treat MRSA by 2011.

The company showed its research at the European Congress on Clinical Microbiology and Infectious Diseases in Barcelona in April.

The compound, called XF-73, is able to kill bacteria. Conventional antibiotic treatment for hospital infections are "bacteriostatic" (it prevents bacteria multiplying).

Studies of the drug revealed that when MRSA was exposed to XF-73 55 times, it was not able to develop a resistance to it. The drug was also able to kill the "five most common strains" of the superbug during testing.

The latest statistics showed that there were over one thousand cases of the superbug from October to December 2007.

Destiny Pharma's chief executive, Dr Bill Love, spoke to the Independent on Sunday.

"The potential is really quite amazing," he said.

He stated that he hoped the health service would support the compound if it was approved by the National Institute for Clinical Excellence.

A Department of Health spokesman stated that they would keep "a close watch" on all new research related to MRSA.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016